Arata Corporation · TSE:2733

Arata — Q1 FY2027 Earnings Presentation

14 slides from Arata's earnings presentation, Aug 7, 2026

  1. Slide 1: Q1 of Fiscal year ending March 2027 Financial results presentation materials

    NOTICE The slides in this presentation have been translated using a mechanical automatic translation service. In some cases, the translation may be inaccurate or unintended. Please use these materials with the understanding that translations are not always accurate. Q1 of Fiscal year ending March 20

  2. Slide 2: Q1 FY27/3 Financial Highlights

    Q1 FY27/3 Financial Highlights Progress of Q1 is in line with the plan for the FY27/3 Continue to promote the Medium-Term Management Plan 2030 Strategy and strengthen the profit structure Net sales : Record highs for the 12th consecutive year Profits : The growth in SG&A ratio outpaced the gross pro

  3. Slide 3: Q1 FY27/3 Results Summary

    Q1 FY27/3 Results Summary Q1 FY26/3 Q1 FY27/3 FY27/3 Progress rate YoY change (Millions of JPY) Results Results Target Rate (%) Changes Rate (%) Net sales 251,192 263,755 1,030,000 25.6% +12,562 105.0 24,909 25,681 +771 Gross profit (9.9) (9.7) - - (▲0.2p) 103.1 20,843 22,586 +1,742 SG&A expenses (8

  4. Slide 4: Factors for Changes in Operating profit

    Q1 FY27/3 Factors for Changes in Operating profit Q1 FY26/3 (Millions of JPY) 562 4,710 ▲ 380 ▲ 260 4,065 ▲ 287 ▲ 279 Q1 FY25/3 Net Sales Gross margin Personnel Expenses Logistics Costs Other SG&A expenses Q1 FY26/3 ＜Increase＞ ＜Decrease＞ ＜Increase＞ ＜Increase＞ ＜Increase＞ Q1 FY27/3 1,245 (Millions of

  5. Slide 5: Net Sales by Category (YoY)

    Net Sales by Category (YoY) (Millions of JPY) 100,000 108.3% H&B 84,103 Q1 FY26/3 Q1 FY27/3 ・Expansion of in-store share 77,635 ・Strong sales of exclusive and preferential distribution items ・Impact of new consolidation of msh Inc. and 102.7% 100.3% Polite Inc. 48,202 47,109 103.2% Home Care 50,000

  6. Slide 6: Net Sales by Business Category (YoY)

    Net Sales by Business Category (YoY) (Millions of JPY) 105.5% 137,400 Drugstores Q1 FY26/3 140,000 130,281 Q1 FY27/3 ・Increase due to inbound demand ・Expansion of in-store share 120,000 100,000 Discount Stores ・Increase due to inbound demand 80,000 ・Expansion of in-store share ・Changes in Consumptio

  7. Slide 7: Gross Profit

    Q1 FY27/3 Gross Profit Point YoY +JPY771 million Gross profit margin declined due to an (Millions of JPY) (%) (▲0.2p) increase in center fees, etc. 30,000 Gross Profit Gross Profit margin 15 24,909 25,681 24,726 Internal factors 25,000 23,221 21,534 ・Increase in gross profit due to increase in sales

  8. Slide 8: SG&A Expenses

    Q1 FY27/3 SG&A Expenses YoY Point (Millions of JPY) +JPY1,742 million (%) Personnel expenses Logistics costs (+0.3p) Impact of M&A and increase in various 30,000 Other costs SG&A ratio 10 expenses due to inflation 8.6 8.2 8.1 8.3 25,000 8.0 22,586 8 Internal factors 20,843 20,016 ・Generation of good

  9. Slide 9: Consolidated Balance Sheets

    Q1 FY27/3 Consolidated Balance Sheets FY26/3 (Millions of JPY) Q1 FY27/3 (Millions of JPY) C u r rent C u r rent C u r rent as s et s C u r rent as s et s l i ab i l i t i es l i ab i l i t i es Main factors 178,533 183,870 ● Current assets +JPY3,916 million (+) Notes and accounts receivable JPY15,8

  10. Slide 10: Progress against Q2 and full-year targets

    Q1 FY27/3 Progress Achieved 50% progress against Q2 target and 25% progress against the full-year target Progressing according to plan Q1 FY27/3 Q2 FY27/3 FY27/3 Progress rate Progress rate (Millions of JPY) Results Target Full-Year Target Net sales 263,755 518,000 50.9% 1,030,000 25.6% 3,095 5,680

  11. Slide 11: Topics ① Renewal of corporate website to strengthen information dissemination

    Topics ① Renewal of corporate website to strengthen information dissemination In August 2026, we completely revamped the Japanese version of our corporate website. Through faster and more comprehensive information disclosure, we will build greater stakeholder trust and strive to further enhance corp

  12. Slide 12: Topics ② ESG assessment

    Topics ② ESG assessment Rating agency Rating Name FY24/3 FY25/3 FY26/3 Positioning 7-point evaluation MSCI (U.S.) ESG Rating AA AAA AAA 0-5 scale FTSE (U.K.) ESG Rating 1.7 2.3 3.0 Lower is better Sustainalytics ESG Risk Rating 14.8 14.3 ー (Netherlands) (As of May 2025) 8-point evaluation CDP (U.K.)

  13. Slide 13: Forward-looking statements / IR inquiries

    Forward-looking statements  This material is provided for informational purposes only and does not solicit any action. This material (including business plans) was prepared by the company based on reliable information available at the time, and includes risks and uncertainties; ARATA CORPORATION be

  14. Slide 14: Copyright ARATA Corp. All Rights Reserved

    Copyright ARATA Corp. All Rights Reserved 14

Arata — Q1 FY2027 Earnings Presentation on 6ix